dc.contributor.author
Tan, Anna C. S.
dc.contributor.author
Schwartz, R.
dc.contributor.author
Anaya, D.
dc.contributor.author
Chatziralli, I.
dc.contributor.author
Yuan, M.
dc.contributor.author
Cicinelli, M. V.
dc.contributor.author
Faes, L.
dc.contributor.author
Mustapha, M.
dc.contributor.author
Phasukkijwatana, Nopasak
dc.contributor.author
Pohlmann, Dominika
dc.contributor.author
Reynolds, Rhianon
dc.contributor.author
Rosenblatt, Amir
dc.contributor.author
Savastano, A.
dc.contributor.author
Touhami, S.
dc.contributor.author
Vaezi, K.
dc.contributor.author
Ventura, Camila V.
dc.contributor.author
Vogt, D.
dc.contributor.author
Ambati, Jayakrishna
dc.contributor.author
Smet, M. D. de
dc.contributor.author
Loewenstein, A.
dc.contributor.author
International Retina Collaborative
dc.date.accessioned
2024-01-11T15:49:33Z
dc.date.available
2024-01-11T15:49:33Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/42004
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-41727
dc.description.abstract
Tertiary outpatient ophthalmology clinics are high-risk environments for COVID-19 transmission, especially retina clinics, where regular follow-up is needed for elderly patients with multiple comorbidities. Intravitreal injection therapy (IVT) for chronic macular diseases, is one of the most common procedures performed, associated with a significant burden of care because of the vigorous treatment regimen associated with multiple investigations. While minimizing the risk of COVID-19 infection transmission is a priority, this must be balanced against the continued provision of sight-saving ophthalmic care to patients at risk of permanent vision loss. This review aims to give evidence-based guidelines on managing IVT during the COVID-19 pandemic in common macular diseases such as age-related macular degeneration, diabetic macula edema and retinal vascular disease and to report on how the COVID-19 pandemic has affected IVT practices worldwide.
To illustrate some real-world examples, 18 participants in the International Retina Collaborative, from 15 countries and across four continents, were surveyed regarding pre- and during- COVID-19 pandemic IVT practices in tertiary ophthalmic centers. The majority of centers reported a reduction in the number of appointments to reduce the risk of the spread of COVID-19 with varying changes to their IVT regimen to treat various macula diseases. Due to the constantly evolving nature of the COVID-19 pandemic, and the uncertainty about the normal resumption of health services, we suggest that new solutions for eye healthcare provision, like telemedicine, may be adopted in the future when we consider new long-term adaptations required to cope with the COVID-19 pandemic.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Intravitreal injections
en
dc.subject
Age-related macular degeneration
en
dc.subject
Diabetic macula edema
en
dc.subject
Practice patterns
en
dc.subject
Recommendations
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Are intravitreal injections essential during the COVID-19 pandemic? Global preferred practice patterns and practical recommendations
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
33
dcterms.bibliographicCitation.doi
10.1186/s40942-022-00380-6
dcterms.bibliographicCitation.journaltitle
International Journal of Retina and Vitreous
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
8
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35672810
dcterms.isPartOf.eissn
2056-9920